More Press Releases

View Older Stories View Newer Stories

Jan 10, 2025 08:30AM Terranet announces Lars Lindell as new CEO
Jan 10, 2025 08:30AM Samsung Bioepis and Teva Enter into a Strategic Partnership for Commercialization of EPYSQLI® (eculizumab-aagh) in the United States
Jan 10, 2025 08:26AM Amylyx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Jan 10, 2025 08:22AM Kenson Investments Launches Revolutionary App to Simplify Financial Management for Clients
Jan 10, 2025 08:23AM LAVA Doses First Patient in Phase 1 LAVA-1266 Study in Hematological Cancers
Jan 10, 2025 08:20AM 2024 Marks Breakout Year for China's ETF Market with Unprecedented Growth
Jan 10, 2025 08:18AM Orexo announces positive topline data from clinical study of OX640 in subjects with and without allergic rhinitis
Jan 10, 2025 08:17AM Increased Spackman Equities Group Inc. Market Activity
Jan 10, 2025 08:18AM Diana Shipping Inc. Announces Time Charter Contract for m/v New York With SwissMarine
Jan 10, 2025 08:17AM New Kearney GBPC report, World in flux, highlights five wildcards that could dramatically shape the global outlook and the operating environment for business over the next five years
Jan 10, 2025 08:15AM Green Leaf Innovations, Inc. 40 Billion Authorized Share Reduction Update
Jan 10, 2025 08:15AM Rail Vision Receives Purchase Order from One of the Leading Central America Freight Rail Operators
Jan 10, 2025 08:15AM Consensus estimates on Tryg A/S
Jan 10, 2025 08:14AM Keeper Security's Paul Aronhime Named a Top Public Sector Leader to Watch in 2025
Jan 10, 2025 08:13AM Is Spring Break 2025 the Most Expensive Yet? Here's What You Need to Know
Jan 10, 2025 08:12AM APLT LEGAL NEWS: BFA Law Announces That a Class Action Lawsuit has Been Filed Against Applied Therapeutics, Inc. and Urges Investors with Losses to Contact the Firm
Jan 10, 2025 08:11AM ZETA LEGAL NEWS: BFA Law Announces That a Class Action Lawsuit has Been Filed Against Zeta Global and Urges Investors with Losses to Contact the Firm
Jan 10, 2025 08:11AM SYM LEGAL NEWS: BFA Law Announces That a Class Action Lawsuit has Been Filed Against Symbotic Inc. and Urges Investors with Losses to Contact the Firm
Jan 10, 2025 08:11AM PACS LEGAL NEWS: BFA Law Announces That a Class Action Lawsuit has Been Filed Against PACS Group, Inc. and Urges Investors with Losses to Contact the Firm
Jan 10, 2025 08:11AM NXT LEGAL NEWS: BFA Law Announces That a Class Action Lawsuit has Been Filed Against Nextracker Inc. and Urges Investors with Losses to Contact the Firm
Jan 10, 2025 08:11AM MQ LEGAL NEWS: BFA Law Announces That a Class Action Lawsuit has Been Filed Against Marqeta, Inc. and Urges Investors with Losses to Contact the Firm
Jan 10, 2025 08:11AM CPRI LEGAL NEWS: BFA Law Announces That a Class Action Lawsuit has Been Filed Against Capri Holdings Limited and Urges Investors with Losses to Contact the Firm
Jan 10, 2025 08:11AM BIOA LEGAL NEWS: BFA Law Announces that a Class Action Lawsuit has Been Filed Against BioAge Labs, Inc. and Urges Investors with Losses to Contact the Firm
Jan 10, 2025 08:11AM ASML LEGAL NEWS: BFA Law Announces That a Class Action Lawsuit has Been filed Against ASML Holding N.V. and Urges Investors with Losses to Contact the Firm
Jan 10, 2025 08:09AM Ethema Completes Acquisition of Kentucky Treatment Operations
Jan 10, 2025 08:10AM HFSA and Elsevier Announce Inaugural Editor-in-Chief of New Journal of Cardiac Failure-Intersections
Jan 10, 2025 08:10AM Issue of Equity and Total Voting Rights
Jan 10, 2025 08:08AM Joint Stock Company Kaspi.kz Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court f
Jan 10, 2025 08:07AM Venu Holding Corporation to Ring Opening Bell at New York Stock Exchange, Celebrating Bold Fan-Founded and Fan-Owned Mission
Jan 10, 2025 08:07AM High Roller Technologies Welcomes Kristofer Muscat as Chief Operating Officer
Jan 10, 2025 08:05AM TD SYNNEX Reports Fiscal 2024 Fourth Quarter and Full Year Results
Jan 10, 2025 08:05AM MetaVia to Hold Advisory Committee Meeting at the 9th Annual MASH-TAG 2025 Conference
Jan 10, 2025 08:05AM Avantor® to Report Fourth Quarter and Full Year 2024 Earnings on Friday, February 7, 2025
Jan 10, 2025 08:05AM OrthoPediatrics Corp. Announces Expansion of Specialty Bracing Division
Jan 10, 2025 08:05AM NextCure Announces First Patient Dosed in the Phase 1 Study of LNCB74 (B7-H4 ADC) as Therapeutic for Treating Multiple Cancers
Jan 10, 2025 08:05AM BTCS Launches Innovative Staker Protection Plan
Jan 10, 2025 08:05AM TrailRunner International Announces New Leadership Appointments
Jan 10, 2025 08:04AM HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Conduct Investor Workshop at the Mar-A-Lago Club
Jan 10, 2025 08:03AM NCCN Guidelines Updated to Include ctDNA-MRD Testing Recommendation for B-Cell Lymphoma
Jan 10, 2025 08:02AM Is Spring Break 2025 the Most Expensive Yet? Here's What You Need to Know
Jan 10, 2025 08:00AM LongPoint Announces a Filing of the Preliminary Prospectus for Return Stacked Global Balanced & Macro ETF ("RGBM")
Jan 10, 2025 08:02AM Chemify Hires Biopharma Veteran Dr. Alastair Leighton as Chief Operating Officer
Jan 10, 2025 08:00AM EllisDon’s Executive Chair, Geoff Smith, Honoured with the 2025 Toronto Region Builder Award
Jan 10, 2025 08:01AM Harbour BioMed Announces License Agreement with Windward Bio for HBM9378/SKB378, an Anti-TSLP Fully Human Antibody for Immunological Diseases
Jan 10, 2025 08:01AM Diamond Lake Minerals (OTC: DLMI) Acquires Solutions™ Naturopathic & SoftWave Acupuncture Clinics to Pioneer Nationwide Expansion of Non-Invasive Medical Treatments
Jan 10, 2025 08:00AM Elektros Expands AI Data Center Initiative with Focus on Small Language Models and Vector Databases
Jan 10, 2025 08:00AM Aspira Women's Health Announces the Appointment of Mike Buhle as SVP of Commercial Operations
Jan 10, 2025 08:00AM Volcon MN1 Unit Arrives at Cycle Plaza Corpus Christi, Ready to Sell
Jan 10, 2025 08:00AM Totus Medicines Announces Successful Completion of a Phase 1 Dose-Escalation Study and Initiation of an Expansion Trial Evaluating TOS-358, a Covalent PI3Ka Selective Therapy for the Treatment of Sele
Jan 10, 2025 08:00AM RESTEM Provides Corporate Update and Announces Key Business Objectives for 2025
View Newer Stories View Older Stories